AI MARKET SCANNING

Xencor, Inc.

📅 Next Catalyst: Nov 04, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.96%
MAX GAP RECORD +10.69%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $XNCR
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+10.69%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
-2.84%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
+3.76%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
+0.21%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+2.14%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-1.69%
Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN)
+2.99%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.1%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $XNCR

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗